[1]
N. J. Sweiss, “Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 31, no. 1, pp. 46–54, Apr. 2014.